Business Context and Reporting Period
This Form 8-K Current Report, dated February 5, 2021, details the resolution of significant litigation involving Citizens, Inc. (the "Company") and the Harold E. Riley Foundation (the "Foundation"). The filing addresses the settlement of the "Colorado Litigation" regarding board nominations and the "Texas Suit" involving the Foundation's beneficiaries. The reporting period covers events finalized on February 5 and February 6, 2021.
Key Financial Metrics and Agreements
- Share Repurchase: The Company entered into a Purchase and Sale Agreement to acquire 100% of the Foundation's Class B common stock (1,001,714 shares).
- Transaction Value: The aggregate purchase price is $9,090,463.80, calculated at $9.08 per share.
- Closing Date: The transaction is scheduled to close on or about March 5, 2021.
- Regulatory Requirements: The transfer of Class B shares, which confers control, requires regulatory approvals from insurance regulators in Colorado, Louisiana, Mississippi, Texas, and Bermuda.
- Financial Statements: This filing does not contain audited financial statements, revenue, profit, cash flow, or debt metrics. It focuses on legal settlements and corporate governance changes.
Material Changes and Governance Actions
- Board Composition: The Board size was reduced from 13 to 9 directors. The composition was restored to the form existing on August 12, 2020, consisting of four Class A directors, four Class B directors, and one Class B vacancy.
- Bylaws Amendment: The Company amended its Bylaws to change voting standards for Board actions and Bylaw alterations from a supermajority (2/3) requirement to a simple majority standard.
- Litigation Dismissal: All claims, counterclaims, and third-party claims in the Colorado Litigation and the Texas Suit have been dismissed with prejudice following mutual settlement agreements.
- Control Transfer: The Foundation agreed to sell its Class B shares, effectively divesting its control over the Company's board nominations. The Company intends to hold these shares as authorized but unissued stock post-closing.
Outlook, Risks, and Contingencies
- Regulatory Risk: The completion of the Class B share purchase is contingent upon obtaining necessary regulatory approvals from multiple jurisdictions.
- Legal Resolution: The settlements include mutual releases for conduct prior to February 5, 2021, resolving disputes regarding fiduciary duties and alleged fraud.
- Management Commentary: The filing indicates a return to the governance structure and bylaws in place prior to the dispute, aiming to stabilize the Company's leadership.
Investor Verification Checklist
- Verify the status of regulatory approvals required in Colorado, Louisiana, Mississippi, Texas, and Bermuda for the Class B share transfer.
- Confirm the final closing date of the $9.09 million share repurchase transaction.
- Review the full text of the "Foundation Settlement Agreement" (Exhibit 10.1) and "Purchase and Sale Agreement" (Exhibit 10.3) for undisclosed conditions.
- Monitor the Company's capital allocation to ensure the $9.09 million purchase price is funded without impacting liquidity.
- Check for any subsequent filings regarding the appointment of a director to fill the remaining Class B vacancy.